在重症监护室的右心力衰竭:病因,发病,诊断和治疗
Elizabeth Tarras1, Akhil Khosla1, Paul M Heerdt2
1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Yale New Haven Hospital and Yale School of Medicine, New Haven, CT, USA.
Journal of intensive care medicine
|November 30, 2023
概括
右心脏衰竭 (RH) 是一种严重的疾病,需要集中治疗. 本综述指导RH衰竭的诊断和管理,涵盖生理学,血液动力学和不断变化的治疗选择,以获得更好的患者结果.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 肺部病理学 肺部病理学
背景情况:
- 右心 (RH) 衰竭呈现复杂的心肺生理学和不同的临床表现.
- 由于高发病率和死亡率,对RH衰竭的管理至关重要.
- 密集治疗师在治疗RH衰竭患者方面发挥着关键作用.
研究的目的:
- 提供关于在重症监护室 (ICU) 诊断和管理RH衰竭的临床指导.
- 审查RH衰竭的病理生理表现和血液动力学.
- 要突出不断发展的药物疗法和RH衰竭的机械循环支持选项.
主要方法:
- 文献综述侧重于RH衰竭的诊断和管理.
- 分析当前的治疗策略,包括药物治疗和机械支持.
- 综合有关RH循环生理学和病理生理学的信息.
主要成果:
- 红衰竭需要对其独特的生理学和血液动力学有专门的了解.
- 治疗选择是多样化的,并且快速发展,针对RH系统的特定组件.
- 有效的管理需要密集专家的综合方法.
结论:
- 了解RH生理学和病理生理学对于重症医生来说至关重要.
- 多学科的方法和对先进疗法的知识可以改善RH失败的结果.
- 本综述作为一个临床指南,用于ICU管理的RH失败.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Acute Respiratory Failure-V
142
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142
Cardiac Catheterization II: Right Heart Catheterization
23
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
23
Acute Respiratory Failure-II
241
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
241
Acute Respiratory Failure-I
213
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
213
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436


